{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:36:45Z","timestamp":1794742605933,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF19040"],"award-info":[{"award-number":["MCRF19040"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1146192"],"award-info":[{"award-number":["1146192"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1162921"],"award-info":[{"award-number":["APP1162921"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1184637"],"award-info":[{"award-number":["APP1184637"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2011767"],"award-info":[{"award-number":["APP2011767"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2020900"],"award-info":[{"award-number":["APP2020900"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA279891"],"award-info":[{"award-number":["K08 CA279891"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA06516"],"award-info":[{"award-number":["P30 CA06516"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA279891"],"award-info":[{"award-number":["K08 CA279891"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA066996"],"award-info":[{"award-number":["CA066996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>DOT1L and Menin are essential cofactors for the oncogenic activity of MLL fusion proteins (MLL-FPs) in leukaemia. However, the mechanisms underpinning the therapeutic effects of their inhibitors remain unclear. Here we identify a critical role for the non-canonical Polycomb repressive complex 1.1 (PRC1.1) in mediating the cellular responses to DOT1L and Menin inhibitors. Menin inhibition induces PRC1.1-dependent deposition of H2AK119ub to silence a subset of MLL-FP targets, whereas DOT1L inhibition results in a genome-wide increase in H2AK119ub. We show that enhanced PRC1.1 activity arises specifically from the progressive loss of DOT1L-mediated H3K79 methylation, independent of MLL-FP displacement or transcriptional repression. This regulatory crosstalk is conserved across cell types and is driven by direct biochemical antagonism between H3K79 methylation and PRC1 activity. Together, our findings establish DOT1L as a component of transcriptional memory co-opted in leukaemia and suggest it serves as the missing link balancing the opposing forces of the MLL\u2013Polycomb axis.<\/jats:p>","DOI":"10.1038\/s41556-025-01859-8","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:03:26Z","timestamp":1770113006000},"page":"307-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["DOT1L provides transcriptional memory through PRC1.1 antagonism"],"prefix":"10.1038","volume":"28","author":[{"given":"Daniel","family":"Neville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Heikamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Magor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia G.","family":"Dobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Levina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"The","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shania","family":"Alex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Suits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradon","family":"Rumler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uckelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Talarmain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5843-7836","authenticated-orcid":false,"given":"Enid Y. N.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-7093","authenticated-orcid":false,"given":"Andrew C.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9099-4728","authenticated-orcid":false,"given":"Scott A.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2194-8311","authenticated-orcid":false,"given":"Charles C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1085-6094","authenticated-orcid":false,"given":"Chen","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-2619","authenticated-orcid":false,"given":"Omer","family":"Gilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"1859_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MOP.0000000000000365","volume":"28","author":"I Iglesias-Platas","year":"2016","unstructured":"Iglesias-Platas, I. & Monk, D. Nongenomic regulation of gene expression. Curr. Opin. Pediatr. 28, 521\u2013528 (2016).","journal-title":"Curr. Opin. Pediatr."},{"key":"1859_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487\u2013500 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1859_CR3","doi-asserted-by":"publisher","first-page":"R1054","DOI":"10.1016\/j.cub.2013.10.004","volume":"23","author":"DavidS Lorberbaum","year":"2013","unstructured":"Lorberbaum, D. avidS. & Barolo, S. Gene regulation: when analog beats digital. Curr. Biol. 23, R1054\u2013R1056 (2013).","journal-title":"Curr. Biol."},{"key":"1859_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao, S., Allis, C. D. & Wang, G. G. The language of chromatin modification in human cancers. Nat. Rev. Cancer 21, 413\u2013430 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1859_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cell.2017.08.002","volume":"171","author":"B Schuettengruber","year":"2017","unstructured":"Schuettengruber, B. et al. Genome regulation by Polycomb and trithorax: 70 years and counting. Cell 171, 34\u201357 (2017).","journal-title":"Cell"},{"key":"1859_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","volume":"81","author":"A Shilatifard","year":"2012","unstructured":"Shilatifard, A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 81, 65\u201395 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"1859_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","volume":"36","author":"AV Krivtsov","year":"2019","unstructured":"Krivtsov, A. V. et al. A Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia. Cancer Cell 36, 660\u2013673.e11 (2019).","journal-title":"Cancer Cell"},{"key":"1859_CR8","first-page":"258","volume":"25","author":"CE Sparbier","year":"2023","unstructured":"Sparbier, C. E. et al. Targeting Menin disrupts the KMT2A\/B and Polycomb balance to paradoxically activate bivalent genes. Nat. Cell Biol. 25, 258\u2013272 (2023).","journal-title":"Nat. Cell Biol."},{"key":"1859_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2007.09.011","volume":"28","author":"P Trojer","year":"2007","unstructured":"Trojer, P. & Reinberg, D. Facultative heterochromatin: is there a distinctive molecular signature?. Mol. Cell 28, 1\u201313 (2007).","journal-title":"Mol. Cell"},{"key":"1859_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","volume":"22","author":"A Piunti","year":"2021","unstructured":"Piunti, A. & Shilatifard, A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat. Rev. Mol. Cell Biol. 22, 326\u2013345 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1859_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41580-021-00398-y","volume":"22","author":"NP Blackledge","year":"2021","unstructured":"Blackledge, N. P. & Klose, R. J. The molecular principles of gene regulation by Polycomb repressive complexes. Nat. Rev. Mol. Cell Biol. 22, 815\u2013833 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1859_CR12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.molcel.2019.11.021","volume":"77","author":"S Tamburri","year":"2020","unstructured":"Tamburri, S. et al. Histone H2AK119 mono-ubiquitination is essential for Polycomb-mediated transcriptional repression. Mol. Cell 77, 840\u2013856.e5 (2020).","journal-title":"Mol. Cell"},{"key":"1859_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09250-6","volume":"10","author":"MJ Kelly","year":"2019","unstructured":"Kelly, M. J. et al. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis. Nat. Commun. 10, 1347 (2019).","journal-title":"Nat. Commun."},{"key":"1859_CR14","doi-asserted-by":"publisher","first-page":"9901","DOI":"10.1093\/nar\/gkx578","volume":"45","author":"H O\u2019Geen","year":"2017","unstructured":"O\u2019Geen, H. et al. dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression. Nucleic Acids Res. 45, 9901\u20139916 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1859_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molcel.2014.06.005","volume":"55","author":"EM Riising","year":"2014","unstructured":"Riising, E. M. et al. Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide. Mol. Cell 55, 347\u2013360 (2014).","journal-title":"Mol. Cell"},{"key":"1859_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc2736","volume":"9","author":"AP Bracken","year":"2009","unstructured":"Bracken, A. P. & Helin, K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9, 773\u2013784 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1859_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2017.00004","volume":"5","author":"AC Winters","year":"2017","unstructured":"Winters, A. C. & Bernt, K. M. MLL-rearranged leukemias\u2014an update on science and clinical approaches. Front. Pediatr. 5, 4 (2017).","journal-title":"Front. Pediatr."},{"key":"1859_CR18","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1182\/blood-2013-02-474833","volume":"121","author":"T Neff","year":"2013","unstructured":"Neff, T. & Armstrong, S. A. Recent progress toward epigenetic therapies: the example of mixed lineage leukemia. Blood 121, 4847\u20134853 (2013).","journal-title":"Blood"},{"key":"1859_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"1859_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature14888","volume":"525","author":"CY Fong","year":"2015","unstructured":"Fong, C. Y. et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature 525, 538\u2013542 (2015).","journal-title":"Nature"},{"key":"1859_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1101\/gad.1898410","volume":"24","author":"M Mohan","year":"2010","unstructured":"Mohan, M. et al. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev. 24, 574\u2013589 (2010).","journal-title":"Genes Dev."},{"key":"1859_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.tibs.2010.05.006","volume":"35","author":"TK Barth","year":"2010","unstructured":"Barth, T. K. & Imhof, A. Fast signals and slow marks: the dynamics of histone modifications. Trends Biochem. Sci. 35, 618\u2013626 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"1859_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1101\/gad.2015411","volume":"25","author":"E Smith","year":"2011","unstructured":"Smith, E., Lin, C. & Shilatifard, A. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 25, 661\u2013672 (2011).","journal-title":"Genes Dev."},{"key":"1859_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.cell.2018.09.027","volume":"175","author":"K Liang","year":"2018","unstructured":"Liang, K. et al. Targeting processive transcription elongation via SEC disruption for MYC-induced cancer therapy. Cell 175, 766\u2013779.e17 (2018).","journal-title":"Cell"},{"key":"1859_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.seminhematol.2025.08.001","volume":"62","author":"DV Wenge","year":"2025","unstructured":"Wenge, D. V. & Armstrong, S. A. Menin inhibition for the treatment of acute leukemia. Semin. Hematol. 62, 187\u2013195 (2025).","journal-title":"Semin. Hematol."},{"key":"1859_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa, G. C. et al. The Menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615, 920\u2013924 (2023).","journal-title":"Nature"},{"key":"1859_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1200\/JCO.24.00826","volume":"43","author":"GC Issa","year":"2025","unstructured":"Issa, G. C. et al. Menin inhibition with revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101). J. Clin. Oncol. 43, 75\u201384 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1859_CR28","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","volume":"131","author":"EM Stein","year":"2018","unstructured":"Stein, E. M. et al. The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia. Blood 131, 2661\u20132669 (2018).","journal-title":"Blood"},{"key":"1859_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","volume":"27","author":"D Borkin","year":"2015","unstructured":"Borkin, D. et al. Pharmacologic inhibition of the Menin\u2013MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell 27, 589\u2013602 (2015).","journal-title":"Cancer Cell"},{"key":"1859_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","volume":"122","author":"SR Daigle","year":"2013","unstructured":"Daigle, S. R. et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 122, 1017\u20131025 (2013).","journal-title":"Blood"},{"key":"1859_CR31","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41594-023-01087-4","volume":"30","author":"O Gilan","year":"2023","unstructured":"Gilan, O. et al. CRISPR\u2013ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia. Nat. Struct. Mol. Biol. 30, 1592\u20131606 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1859_CR32","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.molcel.2022.02.013","volume":"82","author":"SN Olsen","year":"2022","unstructured":"Olsen, S. N. et al. MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape. Mol. Cell 82, 1140\u20131155.e11 (2022).","journal-title":"Mol. Cell"},{"key":"1859_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.ccell.2014.10.009","volume":"26","author":"AJ Deshpande","year":"2014","unstructured":"Deshpande, A. J. et al. AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes. Cancer Cell 26, 896\u2013908 (2014).","journal-title":"Cancer Cell"},{"key":"1859_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.celrep.2015.12.034","volume":"14","author":"V van den Boom","year":"2016","unstructured":"van den Boom, V. et al. Non-canonical PRC1.1 targets active genes independent of H3K27me3 and is essential for leukemogenesis. Cell Rep. 14, 332\u2013346 (2016).","journal-title":"Cell Rep."},{"key":"1859_CR35","doi-asserted-by":"publisher","first-page":"102435","DOI":"10.1016\/j.isci.2021.102435","volume":"24","author":"H Maat","year":"2021","unstructured":"Maat, H. et al. The USP7\u2013TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia. iScience 24, 102435 (2021).","journal-title":"iScience"},{"key":"1859_CR36","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1073\/pnas.1202258109","volume":"109","author":"T Neff","year":"2012","unstructured":"Neff, T. et al. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc. Natl Acad. Sci. USA 109, 5028\u20135033 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1859_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.stem.2017.12.002","volume":"22","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. A Non-canonical BCOR-PRC1.1 complex represses differentiation programs in human ESCs. Cell Stem Cell 22, 235\u2013251.e9 (2018).","journal-title":"Cell Stem Cell"},{"key":"1859_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nsmb.3249","volume":"23","author":"O Gilan","year":"2016","unstructured":"Gilan, O. et al. Functional interdependence of BRD4 and DOT1L in MLL leukemia. Nat. Struct. Mol. Biol. 23, 673\u2013681 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1859_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24894-z","volume":"12","author":"H Sugishita","year":"2021","unstructured":"Sugishita, H. et al. Variant PCGF1\u2013PRC1 links PRC2 recruitment with differentiation-associated transcriptional inactivation at target genes. Nat. Commun. 12, 5341 (2021).","journal-title":"Nat. Commun."},{"key":"1859_CR40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nsmb.2833","volume":"21","author":"R Kalb","year":"2014","unstructured":"Kalb, R. et al. Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression. Nat. Struct. Mol. Biol. 21, 569\u2013571 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1859_CR41","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.cell.2014.05.004","volume":"157","author":"NP Blackledge","year":"2014","unstructured":"Blackledge, N. P. et al. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and Polycomb domain formation. Cell 157, 1445\u20131459 (2014).","journal-title":"Cell"},{"key":"1859_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2018.10.028","volume":"73","author":"EJ Chory","year":"2019","unstructured":"Chory, E. J. et al. Nucleosome turnover regulates histone methylation patterns over the genome. Mol. Cell 73, 61\u201372.e3 (2019).","journal-title":"Mol. Cell"},{"key":"1859_CR43","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41588-021-00964-2","volume":"53","author":"D Holoch","year":"2021","unstructured":"Holoch, D. et al. A cis-acting mechanism mediates transcriptional memory at Polycomb target genes in mammals. Nat. Genet. 53, 1686\u20131697 (2021).","journal-title":"Nat. Genet."},{"key":"1859_CR44","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/sj.emboj.7601144","volume":"25","author":"G Buchwald","year":"2006","unstructured":"Buchwald, G. et al. Structure and E3-ligase activity of the Ring\u2013Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J. 25, 2465\u20132474 (2006).","journal-title":"EMBO J."},{"key":"1859_CR45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.celrep.2015.04.004","volume":"11","author":"A Kuntimaddi","year":"2015","unstructured":"Kuntimaddi, A. et al. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 di- and tri-methylation on target genes and transformation potential. Cell Rep. 11, 808\u2013820 (2015).","journal-title":"Cell Rep."},{"key":"1859_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245\u2013254 (2003).","journal-title":"Nat. Genet."},{"key":"1859_CR47","first-page":"267","volume":"14","author":"KH Wrighton","year":"2013","unstructured":"Wrighton, K. H. Transcription kinetics. Nat. Rev. Mol. Cell Biol. 14, 267\u2013267 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1859_CR48","doi-asserted-by":"publisher","first-page":"R644","DOI":"10.1016\/j.cub.2016.06.011","volume":"26","author":"S Henikoff","year":"2016","unstructured":"Henikoff, S. & Greally, J. M. Epigenetics, cellular memory and gene regulation. Curr. Biol. 26, R644\u2013R648 (2016).","journal-title":"Curr. Biol."},{"key":"1859_CR49","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41588-024-01749-z","volume":"56","author":"CC Bell","year":"2024","unstructured":"Bell, C. C. et al. Comparative cofactor screens show the influence of transactivation domains and core promoters on the mechanisms of transcription. Nat. Genet. 56, 1181\u20131192 (2024).","journal-title":"Nat. Genet."},{"key":"1859_CR50","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13059-024-03461-x","volume":"25","author":"CC Bell","year":"2024","unstructured":"Bell, C. C., Faulkner, G. J. & Gilan, O. Chromatin-based memory as a self-stabilizing influence on cell identity. Genome Biol. 25, 320 (2024).","journal-title":"Genome Biol."},{"key":"1859_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","volume":"20","author":"KM Bernt","year":"2011","unstructured":"Bernt, K. M. et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20, 66\u201378 (2011).","journal-title":"Cancer Cell"},{"key":"1859_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41594-024-01452-x","volume":"32","author":"T Cookis","year":"2025","unstructured":"Cookis, T. et al. Structural basis for the inhibition of PRC2 by active transcription histone posttranslational modifications. Nat. Struct. Mol. Biol. 32, 393\u2013404 (2025).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1859_CR53","doi-asserted-by":"publisher","first-page":"eadt8765","DOI":"10.1126\/sciadv.adt8765","volume":"11","author":"EW Cooke","year":"2025","unstructured":"Cooke, E. W. et al. H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells. Sci. Adv. 11, eadt8765 (2025).","journal-title":"Sci. Adv."},{"key":"1859_CR54","doi-asserted-by":"publisher","first-page":"114901","DOI":"10.1016\/j.celrep.2024.114901","volume":"43","author":"EB Heikamp","year":"2024","unstructured":"Heikamp, E. B. et al. NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML. Cell Rep. 43, 114901 (2024).","journal-title":"Cell Rep."},{"key":"1859_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ccell.2016.05.019","volume":"30","author":"M Ghisi","year":"2016","unstructured":"Ghisi, M. et al. Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia. Cancer Cell 30, 59\u201374 (2016).","journal-title":"Cancer Cell"},{"key":"1859_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cels.2017.02.013","volume":"4","author":"S Berry","year":"2017","unstructured":"Berry, S., Dean, C. & Howard, M. Slow chromatin dynamics allow polycomb target genes to filter fluctuations in transcription factor activity. Cell Syst. 4, 445\u2013457.e8 (2017).","journal-title":"Cell Syst."},{"key":"1859_CR57","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1255023","volume":"345","author":"LJ Gaydos","year":"2014","unstructured":"Gaydos, L. J., Wang, W. & Strome, S. Gene repression. H3K27me and PRC2 transmit a memory of repression across generations and during development. Science 345, 1515\u20131518 (2014).","journal-title":"Science"},{"key":"1859_CR58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41587-021-00837-3","volume":"39","author":"BL Emert","year":"2021","unstructured":"Emert, B. L. et al. Variability within rare cell states enables multiple paths toward drug resistance. Nat. Biotechnol. 39, 865\u2013876 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1859_CR59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.stemcr.2021.12.004","volume":"17","author":"CK Wille","year":"2022","unstructured":"Wille, C. K. & Sridharan, R. DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome. Stem Cell Rep. 17, 384\u2013396 (2022).","journal-title":"Stem Cell Rep."},{"key":"1859_CR60","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nature10953","volume":"483","author":"TT Onder","year":"2012","unstructured":"Onder, T. T. et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598\u2013602 (2012).","journal-title":"Nature"},{"key":"1859_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nbt.2800","volume":"32","author":"H Koike-Yusa","year":"2014","unstructured":"Koike-Yusa, H. et al. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267\u2013273 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1859_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.aaz8455","volume":"368","author":"O Gilan","year":"2020","unstructured":"Gilan, O. et al. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation. Science 368, 387\u2013394 (2020).","journal-title":"Science"},{"key":"1859_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6478-3","volume":"21","author":"G Sholder","year":"2020","unstructured":"Sholder, G. et al. 3\u2032Pool-seq: an optimized cost-efficient and scalable method of whole-transcriptome gene expression profiling. BMC Genomics 21, 64 (2020).","journal-title":"BMC Genomics"},{"key":"1859_CR64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s43018-022-00366-1","volume":"3","author":"BJ Aubrey","year":"2022","unstructured":"Aubrey, B. J. et al. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nat. Cancer 3, 595\u2013613 (2022).","journal-title":"Nat. Cancer"},{"key":"1859_CR65","doi-asserted-by":"publisher","first-page":"168943","DOI":"10.1016\/j.jmb.2025.168943","volume":"437","author":"Z Lai","year":"2025","unstructured":"Lai, Z. et al. Modular cloning of multigene vectors for the baculovirus system and yeast. J. Mol. Biol. 437, 168943 (2025).","journal-title":"J. Mol. Biol."},{"key":"1859_CR66","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41594-019-0197-y","volume":"26","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. RNA exploits an exposed regulatory site to inhibit the enzymatic activity of PRC2. Nat. Struct. Mol. Biol. 26, 237\u2013247 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1859_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41467-017-02653-3","volume":"9","author":"M Uckelmann","year":"2018","unstructured":"Uckelmann, M. et al. USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A. Nat. Commun. 9, 229 (2018).","journal-title":"Nat. Commun."},{"key":"1859_CR68","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cell.2006.12.041","volume":"128","author":"MD Simon","year":"2007","unstructured":"Simon, M. D. et al. The site-specific installation of methyl-lysine analogs into recombinant histones. Cell 128, 1003\u20131012 (2007).","journal-title":"Cell"},{"key":"1859_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-0-12-391940-3.00003-2","volume":"512","author":"MD Simon","year":"2012","unstructured":"Simon, M. D. & Shokat, K. M. A method to site-specifically incorporate methyl-lysine analogues into recombinant proteins. Methods Enzymol. 512, 57\u201369 (2012).","journal-title":"Methods Enzymol."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01859-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:02:39Z","timestamp":1770994959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1859"],"URL":"https:\/\/doi.org\/10.1038\/s41556-025-01859-8","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.A. has been a consultant and\/or shareholder for Neomorph, Cyteir Therapeutics, C4 Therapeutics, Accent Therapeutics, Hyku Therapeutics and Stelexis Therapeutics. S.A.A. has received research support from Janssen, Novartis and Syndax. S.A.A. is an inventor on a patent related to MENIN inhibition WO\/2017\/132398A1. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}